Key result
The letter argues that the primary aim of treating stable angina is providing appropriate medical therapy to reduce the risk of myocardial infarction and sudden death, rather than just symptom relief.
A letter to the editor arguing that the primary aim of treating stable angina is appropriate medical therapy to reduce the risk of myocardial infarction and sudden death, rather than just symptom relief.
To the Editor: In the editorial accompanying the article by Rajkumar and colleagues (Dec. 21 issue) 1 on the results of the ORBITA-2 trial involving the use of percutaneous coronary intervention (PCI) in patients with stable angina, White 2 begins with a flawed premise: “The primary aim of treating patients with stable angina is to decrease symptoms and improve quality of life.” That is not the primary aim of treating these patients. Relieving angina is important, but the real priority in the management of stable angina is the provision of appropriate medical therapy to reduce the risk of myocardial infarction and sudden . . .
No takes yet. Share an insight, caveat, or question.
Nobuhiro Ikemura (2024) conducted a letter in stable angina. percutaneous coronary intervention (PCI) was evaluated. The letter argues that the primary aim of treating stable angina is providing appropriate medical therapy to reduce the risk of myocardial infarction and sudden death, rather than just symptom relief.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: